Immunology of allergen immunotherapy.
Immunology of allergen immunotherapy.
复制标题
DOI:
10.1093/immadv/ltac022
复制
发表时间:
2022
影响因子:
--
通讯作者:
Wesemann, Duane R.
中科院分区:
文献类型:
--
作者:
Rahman, Rifat S.;Wesemann, Duane R.
Allergen immunotherapy (AIT) is the only disease-modifying therapy for allergic disease. Through repeated inoculations of low doses of allergen—either as whole proteins or peptides—patients can achieve a homeostatic balance between inflammatory effectors induced and/or associated with allergen contact, and mediators of immunologic non-responsiveness, potentially leading to sustained clinical improvements. AIT for airborne/respiratory tract allergens and insect venoms have traditionally been supplied subcutaneously, but other routes and modalities of administration can also be effective. Despite differences of allergen administration, there are some similarities of immunologic responses across platforms, with a general theme involving the restructuring and polarization of adaptive and innate immune effector cells. Here we review the immunology of AIT across various delivery platforms, including subcutaneous, sublingual, epicutaneous, intradermal, and intralymphatic approaches, emphasizing shared mechanisms associated with achieving immunologic non-responsiveness to allergen.
登录
查看更多内容
DOI:
10.1084/jem.20011502
发表时间:
2002-01-07
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Campbell DJ;Butcher EC
通讯作者:
Butcher EC
影响因子:
14.2
作者:
Boonpiyathad, Tadech;van de Veen, Willem;Akdis, Mubeccel
通讯作者:
Akdis, Mubeccel
影响因子:
6.1
作者:
Eifan, A. O.;Akkoc, T.;Barlan, I. B.
通讯作者:
Barlan, I. B.
影响因子:
8.7
作者:
Angelini, Federica;Pacciani, Valentina;Chini, Loredana
通讯作者:
Chini, Loredana
DOI:
10.1111/cea.12312
发表时间:
2014-06
期刊:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
影响因子:
--
作者:
Dioszeghy V;Mondoulet L;Dhelft V;Ligouis M;Puteaux E;Dupont C;Benhamou PH
通讯作者:
Benhamou PH